William J Oshea's Net Worth
$16.5 Million
Who is William J Oshea?
William J Oshea has an estimated net worth of $16.5 Million. This is based on reported shares across multiple companies, which include MAP Pharmaceuticals, Inc., OCULAR THERAPEUTIX, INC, Trevi Therapeutics, Inc., Zalicus Inc., PENWEST PHARMACEUTICALS CO, and SEPRACOR INC /DE/.
SEC CIK
William J Oshea's CIK is 0001251725
Past Insider Trading and Trends
2007 was William J Oshea's most active year for acquiring shares with 17 total transactions. William J Oshea's most active month to acquire stocks was the month of May. 2004 was William J Oshea's most active year for disposing of shares, totalling 23 transactions. William J Oshea's most active month to dispose stocks was the month of April. 2007 saw William J Oshea paying a total of $36,454,800.00 for 1,065,970 shares, this is the most they've acquired in one year. In 2007 William J Oshea cashed out on 979,254 shares for a total of $24,099,200.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MAP Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OCULAR THERAPEUTIX, INC (OCUL) Snapshot price: $8.39
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Trevi Therapeutics, Inc. (TRVI) Snapshot price: $2.95
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +658.81% | 99.05K |
—
|
—
| 114.08K |
May 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Zalicus Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PENWEST PHARMACEUTICALS CO No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +4.40% | 1.71K |
—
|
—
| 40.48K |
Nov 12
| |||
Form 4
| +12.27% | 4.24K |
—
|
—
| 38.78K |
Oct 1
| |||
Form 4
| +1.53% | 519 |
—
|
—
| 34.54K |
Sep 9
| |||
Form 4
| +9.63% | 2.99K |
—
|
—
| 34.02K |
Jul 1
| |||
Form 4
| +1.61% | 492 |
—
|
—
| 31.03K |
Jun 11
| |||
Form 4
| +1.11% | 334 |
—
|
—
| 30.54K |
Apr 24
| |||
Form 4
| +6.57% | 1.83K |
—
|
—
| 29.73K |
Apr 1
| |||
Form 4
| +1.73% | 482 |
—
|
—
| 28.38K |
Feb 27
| |||
Form 4
| +33.02% | 6.92K |
—
|
—
| 27.89K |
Jan 2
| |||
Form 4
| +2.19% | 449 |
—
|
—
| 20.97K |
Oct 1
| |||
Form 4
| +0.60% | 122 |
—
|
—
| 20.52K |
Sep 5
| |||
Form 4
| +2.00% | 399 |
—
|
—
| 20.4K |
Jul 2
| |||
Form 4
|
∞
| 20K |
—
|
—
| 20K |
Jun 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||